Zoonotic potential of CWD and influence of environmental contamination on prion propagation

CWD 的人畜共患潜力以及环境污染对朊病毒传播的影响

基本信息

项目摘要

ABSTRACT Prion diseases are transmissible between animal-to-animal, animal-to-human and human-to- human, however, we still do not understand completely the mechanisms, factors and biological processes controlling the inter-individual transmission of this unique infectious agent. Among animal diseases, chronic wasting disease (CWD) represents a serious problem, because it continues to propagate uncontrollably among wild and captive cervids in North America. The risk of CWD transmission to humans is unknown which is a major concern because the number of sick animals and their geographical distribution is rapidly increasing. The mechanism by which CWD propagates so efficiently among cervids is also unknown, but recent findings have implicated environmental contamination with prions. The main goal of this project is to study the mechanisms controlling the species barrier, particularly to investigate the possibility that CWD may, under determined conditions, infect humans. We will also study the role of environmental contamination in CWD transmission, focusing on plants and various surfaces as vectors for prion propagation. In Specific Aim 1 we will investigate the role of prion strain adaptation in the zoonotic potential of CWD. The hypothesis for these studies is that the species barrier is a dynamic process that changes over time when prion strains mature and evolve. We will study the molecular mechanism of prion strain maturation, the biochemical and structural properties that differentiate CWD strains able and unable to convert human PrPC into PrPSc and analyze a large collection of natural CWD specimens to investigate differences on the strength of the human species barrier in vitro. In Specific Aim 2 we will test the hypothesis that the strength of the species barrier is lower in hosts harboring brain damage associated to other neurological diseases or even to subclinical or pre-clinical conditions. We will investigate whether the cervid/human species barrier can be altered in transgenic mice expressing human PrP by the co-existence of another brain abnormality, using established models of chronic neurodegenerative diseases (Alzheimer's and Parkinson's disease) and acute brain damage (traumatic brain injury and stroke). In Specific Aim 3 we will study the role of plants as fomites for prion transmission by analyzing prion binding to plants, retention of infectivity and transport of PrPSc from soil to different parts of the plants. Studies will be done using natural CWD prions and infectivity experiments will be performed in cultured cells, gene-targeted cervidtransgenic mice and the natural host (white tail deer). We will also test plants collected from CWD affected areas for the presence of PrPSc by PMCA. In Specific Aim 4 we will test the hypothesis that prions buildup in the environment by progressively binding to diverse environmental surfaces, where they can infect animals by simple contact. We will study the binding affinity of PrPSc to various surfaces (including stones, wood, plastic, glass, concrete, stainless steel and aluminum), the time permanence of PrPSc and infectivity in the surface and the effect of environmental changes on infectivity. We will also investigate the transmission of the disease through casual contact with contaminated surfaces and the mechanism by which this happen. The findings generated in this project will contribute to understand the zoonotic potential of CWD, the factors modulating the transmission of this disease, and the role the environment plays on prion transmission. These studies are essential to design measures to prevent further propagation of CWD, and to avoid the emergence of new diseases with potentially disastrous consequences.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLAUDIO SOTO其他文献

CLAUDIO SOTO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLAUDIO SOTO', 18)}}的其他基金

Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
α-突触核蛋白聚集体的充分表征的多态性变体的生产和分布
  • 批准号:
    10706583
  • 财政年份:
    2022
  • 资助金额:
    $ 27.63万
  • 项目类别:
Production and Distribution of well-characterized polymorphic variants of alpha-synuclein aggregates
α-突触核蛋白聚集体的充分表征的多态性变体的生产和分布
  • 批准号:
    10549216
  • 财政年份:
    2022
  • 资助金额:
    $ 27.63万
  • 项目类别:
Comprehensive diagnosis of Alzheimer's disease by detection of misfolded oligomers in biological fluids
通过检测生物体液中错误折叠的寡聚物来全面诊断阿尔茨海默病
  • 批准号:
    9766691
  • 财政年份:
    2019
  • 资助金额:
    $ 27.63万
  • 项目类别:
Blood-based diagnostics for Alzheimer's Disease
阿尔茨海默病的血液诊断
  • 批准号:
    9272025
  • 财政年份:
    2016
  • 资助金额:
    $ 27.63万
  • 项目类别:
Blood-based diagnostics for Alzheimer's Disease
阿尔茨海默病的血液诊断
  • 批准号:
    8834208
  • 财政年份:
    2015
  • 资助金额:
    $ 27.63万
  • 项目类别:
Blood-based diagnostics for Alzheimer's Disease
阿尔茨海默病的血液诊断
  • 批准号:
    9231053
  • 财政年份:
    2015
  • 资助金额:
    $ 27.63万
  • 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
  • 批准号:
    8450044
  • 财政年份:
    2012
  • 资助金额:
    $ 27.63万
  • 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
  • 批准号:
    8299342
  • 财政年份:
    2012
  • 资助金额:
    $ 27.63万
  • 项目类别:
Absorption, Metabolism and Biodistribution of Prions after Oral Ingestion
口服摄入后朊病毒的吸收、代谢和生物分布
  • 批准号:
    8439892
  • 财政年份:
    2012
  • 资助金额:
    $ 27.63万
  • 项目类别:
Cross-seeding of Protein Misfolding as a Disease Mechanism
蛋白质错误折叠作为疾病机制的交叉播种
  • 批准号:
    8829300
  • 财政年份:
    2012
  • 资助金额:
    $ 27.63万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 27.63万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了